Lupo Securities’s Immunogen Inc IMGN Stock Holding History

Lupo Securities’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-300	Closed	-$3K	–	426
2015 Q1	$3K	Sell	300 -700	-70%	-$5.07K	﹤0.01%	393
2014 Q4	$6.1K	Buy	+1,000	New	+$9.14K	﹤0.01%	380

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lupo Securities's IMGN Position: Q2 2015 in Review

Lupo Securities sold out of Immunogen Inc (IMGN) in Q2 2015, closing a stake of 300 shares — an estimated $3K sold.

Lupo Securities first reported a position in IMGN in Q4 2014 and held it in 2 quarters. The position peaked at $6.1K in Q4 2014. 140 funds tracked by Wall St. Rank hold IMGN as of Q2 2015.

Lupo Securities reported no remaining Immunogen Inc position as of Q2 2015 after selling out during the quarter.
Lupo Securities sold 300 Immunogen Inc shares in Q2 2015, an estimated $3K.
Lupo Securities first reported a position in Immunogen Inc in Q4 2014 and held it in 2 quarters.
Lupo Securities's Immunogen Inc position peaked at $6.1K in Q4 2014.
140 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2015.

Based on Lupo Securities's 13F filing for Q2 2015, filed 14 Aug 2015.